-
公开(公告)号:US20050154011A1
公开(公告)日:2005-07-14
申请号:US10633744
申请日:2003-08-04
申请人: Sean Klopfenstein , Matthew Maier , David Jones , Jeffrey Gray , Matthew Pokross , Kevin Peters , Artem Evdokimov
发明人: Sean Klopfenstein , Matthew Maier , David Jones , Jeffrey Gray , Matthew Pokross , Kevin Peters , Artem Evdokimov
IPC分类号: A61P3/10 , A61P43/00 , C07C307/02 , C07C311/19 , C07C311/27 , C07C311/51 , C07C311/53 , C07C323/41 , C07C323/60 , C07D207/16 , C07D211/62 , C07D213/82 , C07D231/40 , C07D233/38 , C07D295/13 , A61K31/4709 , C07D41/02
CPC分类号: C07D213/82 , C07C307/02 , C07C311/19 , C07C311/27 , C07C311/51 , C07C311/53 , C07C323/41 , C07C323/60 , C07C2601/08 , C07D207/16 , C07D211/62 , C07D231/40 , C07D233/38 , C07D295/13
摘要: Compounds of formula (I): are effective in the treatment of protein tyrosine phosphatase (PTPase) mediated disorder such as diabetes.
摘要翻译: 式(I)化合物:在治疗蛋白酪氨酸磷酸酶(PTPase)介导的病症如糖尿病中是有效的。